 CHERRY HILL, N.J., Nov. 09, 2021 GLOBE NEWSWIRE -- Vyant Bio , Inc. Vyant Bio, Company Nasdaq: VYNT, an emerging global drug discovery company, is rapidly identifying small and large molecule therapeutics to treat central nervous system CNS and oncology-related diseases. Today, Vyant Bio announced that an investor conference call and webcast will be hosted on Thursday, November 11, 2021. 